LANTERN PHARMA INC (NASDAQ: LTRN)

LANTERN PHARMA INC

NASDAQ: LTRN (Lantern Pharma Inc.)

Last update: 54 minutes ago

1.93

-0.09 (-4.46%)

Add to watchlist

Previous Close	2.02
Volume	162,607

Price / Book

9.74

52 Weeks Range

1.11 (-42%) — 4.70 (143%)

Market Trend

		Short Term	Medium Term
Industry	Biotechnology (US)	Mixed	Bullish
	Biotechnology (Global)	Mixed	Bullish
Stock	Lantern Pharma Inc.	Mixed	Mixed

AIStockmoo Score

-1.5

Analyst Consensus	NA
Insider Activity	NA
Price Volatility	0.5
Technical Moving Averages	-2.5
Technical Oscillators	-2.5
Average	-1.50

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
LTRN	-	-	-	9.74
MNMD	1 B	-	-	5.42
CVAC	1 B	-	5.08	1.03
HLVX	103 M	-	-	0.710
SONN	33 M	-	-	2.07
FNCH	22 M	-	-	1.07

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Sector	Healthcare
Industry	Biotechnology
Investment Style	Small Value
% Held by Insiders	14.10%
% Held by Institutions	21.12%

Ownership

Name	Date	Shares Held
Empery Asset Management, Lp	30 Jun 2026	842,669
Cm Management, Llc	30 Jun 2026	500,000
Bios Capital Management, Lp	30 Jun 2026	249,397
Westside Investment Management, Inc.	30 Jun 2026	47,850
Quadrature Capital Ltd	30 Jun 2026	39,593
Newedge Advisors, Llc	30 Jun 2026	27,049
Horizon Kinetics Asset Management Llc	30 Jun 2026	25,164
Davenport & Co Llc	30 Jun 2026	23,814

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2026	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Total Debt/Equity (MRQ)	1.16%
Current Ratio (MRQ)	4.86
Operating Cash Flow (TTM)	-19.12 M
Levered Free Cash Flow (TTM)	-11.95 M

Return on Assets (TTM)	-43.68%
Return on Equity (TTM)	-75.66%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)